Drug interactions involving combination antiretroviral therapy and other anti-infective agents: Repercussions for resource-limited countries

Kelly E. Dooley; Charles Flexner; Adriana S. Andrade

doi:10.1086/591459

Drug interactions involving combination antiretroviral therapy and other anti-infective agents: Repercussions for resource-limited countries

Kelly E. Dooley, Charles Flexner, Adriana S. Andrade

School of Medicine

Research output: Contribution to journal › Review article › peer-review

63 Scopus citations

Original language	English (US)
Pages (from-to)	948-961
Number of pages	14
Journal	Journal of Infectious Diseases
Volume	198
Issue number	7
DOIs	https://doi.org/10.1086/591459
State	Published - Oct 1 2008

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

Access to Document

10.1086/591459

Cite this

@article{70549f09f34b498b85e7c447ac0a42a1,

title = "Drug interactions involving combination antiretroviral therapy and other anti-infective agents: Repercussions for resource-limited countries",

author = "Dooley, {Kelly E.} and Charles Flexner and Andrade, {Adriana S.}",

note = "Funding Information: Potential conflicts of interest: C.F. has received research grant support from Bristol Myers-Squibb, Boehringer-Ingelheim, and GlaxoSmithKline; has served as a consultant or scientific advisory–board member for Bristol Myers-Squibb, Boehringer-Ingelheim, Merck Laboratories, Schering-Plough, Tibotec Therapeutics, and Vertex Pharmaceuticals; and has received honoraria from Abbott Laboratories and Gilead Sciences.",

year = "2008",

month = oct,

day = "1",

doi = "10.1086/591459",

language = "English (US)",

volume = "198",

pages = "948--961",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Drug interactions involving combination antiretroviral therapy and other anti-infective agents

T2 - Repercussions for resource-limited countries

AU - Dooley, Kelly E.

AU - Flexner, Charles

AU - Andrade, Adriana S.

N1 - Funding Information: Potential conflicts of interest: C.F. has received research grant support from Bristol Myers-Squibb, Boehringer-Ingelheim, and GlaxoSmithKline; has served as a consultant or scientific advisory–board member for Bristol Myers-Squibb, Boehringer-Ingelheim, Merck Laboratories, Schering-Plough, Tibotec Therapeutics, and Vertex Pharmaceuticals; and has received honoraria from Abbott Laboratories and Gilead Sciences.

PY - 2008/10/1

Y1 - 2008/10/1

UR - http://www.scopus.com/inward/record.url?scp=51849107500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849107500&partnerID=8YFLogxK

U2 - 10.1086/591459

DO - 10.1086/591459

M3 - Review article

C2 - 18713054

AN - SCOPUS:51849107500

SN - 0022-1899

VL - 198

SP - 948

EP - 961

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 7

ER -

Drug interactions involving combination antiretroviral therapy and other anti-infective agents: Repercussions for resource-limited countries

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this